WorldGate Communications wgate.com


Specializes in research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The company went public on February 1, 2005.

Specializes in research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The company went public on February 1, 2005.

Company (IPO / Went public)

Phone: 215-354-5100

Fax:

3190 Tremont Avenue

Trevose, 19053
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
WorldGate Communications $87.8M Jun 15, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related WorldGate Communications Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Adaptive video telephone system Apr 27, 2005 Jan 03, 2012 Patent
Videophone system and method Sep 01, 2006 Nov 22, 2011 Patent